Skip to main content
Premium Trial:

Request an Annual Quote

Investment Firms Begin Coverage of Complete Genomics

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Four investment firms have started coverage on Complete Genomics, a day after the company reported $4.2 million in revenues for the third quarter.

Both UBS and Jefferies initiated coverage with a "Buy" rating, while Cowen and R.W. Baird gave the Mountain View, Calif.-based next-generation sequencing services firm, which went public in November, an "Outperform" rating.

Jefferies has a price target on the company's shares of $13, an 89 percent increase from Complete Genomics' $6.89 closing price on Monday. Both UBS and Baird have a target of $12 per share, while Cowen didn't place a price target on the stock.

In a research note, Quintin Lai of Baird said that Complete Genomics' focus on providing whole human genome sequencing at an affordable, all-in cost positions it uniquely in the market as researchers will be able to sequence whole humans without having to invest heavily in instrument and infrastructure expenses.

He added that its cost and 99.99 percent accuracy makes the company's service appealing to academic and pharma/biotech researchers, and the service could have clinical applications, especially in cancer research.

The National Cancer Institute and others have used its services, and, "[w]e think sequencing orders from these early adopters will help pave the way for large-scale, statistically powerful, studies to follow," Lai said.

In Tuesday afternoon trading on the Nasdaq, shares of Complete Genomics were up almost 9 percent at $7.48 per share.

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.